Oncolytics Biotech Inc. (ONCY)

NASDAQ: ONCY · Real-Time Price · USD

1.035

-0.005 (-0.48%)

Mar 4, 2026, 11:43 AM EST - Market open

Oncolytics Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '26 Mar 4, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	111	70	100	96	76	103
Market Cap Growth	88.45%	-29.42%	3.71%	25.79%	-25.81%	-17.82%
Enterprise Value	104	57	71	73	39	83
Last Close Price	1.04	0.91	1.35	1.63	1.39	2.38
PB Ratio	1355.47	16.94	4.78	4.91	2.68	5.31
P/TBV Ratio	1355.47	16.94	4.78	4.91	2.68	5.31
Debt / Equity Ratio	7.26	0.18	0.02	0.01	0.02	0.02
Net Debt / Equity Ratio	-100.15	-2.49	-1.25	-1.20	-1.12	-1.25
Net Debt / EBITDA Ratio	0.33	0.43	1.02	1.18	1.56	1.22
Net Debt / FCF Ratio	0.44	0.55	1.21	1.36	1.79	1.40
Quick Ratio	1.62	2.39	8.24	8.15	15.37	11.56
Current Ratio	1.84	2.82	9.01	9.05	16.69	12.45
Return on Equity (ROE)	-769.06%	-189.05%	-102.66%	-79.34%	-86.45%	-182.63%
Return on Assets (ROA)	-111.21%	-74.11%	-55.46%	-40.44%	-40.88%	-58.93%
Return on Capital Employed (ROCE)	-472.60%	-259.10%	-97.70%	-80.60%	-60.70%	-80.50%
Earnings Yield	-22.63%	-31.29%	-21.06%	-19.07%	-27.18%	-17.13%
FCF Yield	-17.31%	-26.85%	-21.59%	-17.98%	-23.47%	-16.82%
Buyback Yield / Dilution	-17.39%	-13.10%	-16.53%	-8.44%	-32.66%	-82.22%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q